Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 50,118 | 318 | 463 | 418 | 173 |
| Gross Profit | 50,118 | 318 | 463 | 418 | 173 |
| Operating Expenses | 147,599 | 76,342 | 56,621 | 47,482 | 22,987 |
| Operating Income | -97,481 | -76,024 | -56,158 | -47,064 | -22,814 |
| Other Income | -5,293 | -12,217 | -7,889 | -23,728 | -481 |
| Pre-tax Income | -102,774 | -88,241 | -64,047 | -70,792 | -23,295 |
| Income Tax | -94 | 144 | 73 | N/A | N/A |
| Net Income Continuous | -102,680 | -88,385 | -64,120 | -70,792 | -23,295 |
| Net Income | $-102,680 | $-88,385 | $-64,120 | $-70,792 | $-23,295 |
| EPS Basic Total Ops | -0.87 | -0.95 | -0.76 | -0.92 | -0.66 |
| EPS Basic Continuous Ops | -0.87 | -0.95 | -0.76 | -0.92 | -0.66 |
| EPS Diluted Total Ops | -0.87 | -0.95 | -0.76 | -0.92 | -0.66 |
| EPS Diluted Continuous Ops | -0.87 | -0.95 | -0.76 | -0.92 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.87 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-96,110 | $-74,853 | $-54,711 | $-45,726 | $-21,503 |